0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Neurology |

This Month in Archives of Neurology FREE

Arch Neurol. 2009;66(7):817-818. doi:10.1001/archneurol.2009.148.
Text Size: A A A
Published online

NEW THERAPIES FOR MULTIPLE SCLEROSIS

CohenArticle reviews emerging agents currently under investigation to treat relapsing multiple sclerosis that have shown promise in phase 2 trials.

AGING AND THE HIPPOCAMPUS

Lister and BarnesArticle cover the major age-related alterations in the hippocampus, a critical structure for learning and memory.

VALIDITY OF SELF-REPORTED STROKE

Reitz and colleagues Article conclude that in stroke research, sensitive neuroimaging techniques, rather than stroke self-reporting, should be used to determine stroke history. Article

FOLLOW-UP OF PATIENTS WITH SUBCLINICAL MULTIPLE SCLEROSIS

Lebrun et alArticle provide a longitudinal follow-up of patients with subclinical demyelinating lesions who are asymptomatic. A total of 33% had clinical conversion, with a variety of demyelinating lesions, during a mean time of 5.2 years.

GENOMIC SUSCEPTIBILITY LOCI IN HYPERTENSIVE SIBSHIPS

Turner and colleaguesArticle have correlated susceptibility loci for brain atrophy, ventricular volume, and leukoaraiosis identified by linkage analyses and show that they differ both among magnetic resonance imaging measures and between races.

SMOKING AND DISEASE PROGRESSION IN MULTIPLE SCLEROSIS

Healy et alArticle report that cigarette smoke has an adverse influence on multiple sclerosis progression and accelerates conversion from a relapsing-remitting to a progressive course.

Place holder to copy figure label and caption

Kaplan-Meier curve for time to conversion from relapsing-remitting to secondary progressive multiple sclerosis. Smoking status was defined at study entry. Disease in current smokers progressed significantly faster than in never-smokers (P = .002). Red line indicates current smokers; green line, ex-smokers; and black line, never-smokers.

Graphic Jump Location

FREQUENCY, CHARACTERISTICS, AND RISK FACTORS FOR AMIODARONE NEUROTOXICITY

Orr and AhlskogArticle find that amiodarone, an antiarrhythmic drug prescribed commonly for atrial fibrillation and ventricular arrhythmias, infrequently causes clinically significant neurological toxicity.

ELEVATED SERUM PESTICIDE LEVELS AND RISK OF PARKINSON DISEASE

Richardson and colleaguesArticle show that β-hexachlorocyclohexane (β-HCH) is associated with Parkinson disease. They show that β-HCH is more often detectible in Parkinson disease cases compared with controls or patients with Alzheimer disease.

DEFAULT MODE NETWORK IN PARKINSON DISEASE

Specific malfunctioning of the default mode network during an executive task in Parkinson disease is described by van Eimeren et al. Article

ATRIOESOPHAGEAL FISTULA

Stöllberger and colleaguesArticle describe the occurrence of atrioesophageal fistula with serious neurological complications occurring in patients who have received radiofrequency ablation for atrial fibrillation.

APATHY IN FRONTOTEMPORAL DEMENTIA AND ALZHEIMER DISEASE

Chow et alArticle point out that apathy is common in patients with frontotemporal dementia and in those with Alzheimer disease. When present, it usually involves changes in affect, behavior, and cognition.

Figures

Place holder to copy figure label and caption

Kaplan-Meier curve for time to conversion from relapsing-remitting to secondary progressive multiple sclerosis. Smoking status was defined at study entry. Disease in current smokers progressed significantly faster than in never-smokers (P = .002). Red line indicates current smokers; green line, ex-smokers; and black line, never-smokers.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

211 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs